Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas.
about
Identification of the human YVH1 protein-tyrosine phosphatase orthologue reveals a novel zinc binding domain essential for in vivo functionMolecular cloning of a T cell-specific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sitesMapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGHThe dual-specificity protein phosphatase Yvh1p regulates sporulation, growth, and glycogen accumulation independently of catalytic activity in Saccharomyces cerevisiae via the cyclic AMP-dependent protein kinase cascade.Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradationComparative genomic hybridization and chromosomal instability in solid tumours.Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas.Cytogenetics and molecular biology of osteosarcoma.Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements.DNA copy number changes in development and progression in leiomyosarcomas of soft tissues.Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosisComparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker.DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations.Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcomaRecurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridizationTransgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesisDNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH.The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.Isolation of osteosarcoma-associated amplified DNA sequences using representational difference analysis.How does the Schwann cell lineage form tumors in NF1?A case of an infertile male with a small supernumerary marker chromosome negative for M-FISH and containing only heterochromatin.Liposarcoma: molecular genetics and therapeutics.Contributions of cytogenetics and molecular cytogenetics to the diagnosis of adipocytic tumors.Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization.Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas.Evaluation of chromosome 1q gain in intracranial ependymomas.Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis.Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity.Molecular cytogenetic analysis of consistent abnormalities at 8q12-q22 in breast cancer.Clinical and Molecular Spectrum of Liposarcoma.Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21.Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization.Gains of 13q are correlated with a poor prognosis in liposarcoma
P2860
Q22003727-2AEBA6D7-2AFD-43D2-B9F8-964DAB8A4E1AQ24310780-7846B6DF-BDCC-47CC-B1C5-CA1CBD983F92Q24815629-E5BBB4CC-E350-4C0B-9EF2-A8E3D582D64FQ27936266-7577C287-EBF1-45A2-A87A-42A5C49BC37CQ28201673-C32EBF3F-7C56-480F-A8A9-9B53CE086C50Q33653215-216880BA-0317-4C31-BDB6-274FBFDEBE89Q33826589-68F50677-D040-4DF4-ADF1-0D756B831AABQ34522369-9088EF36-3763-4892-A3C1-9FDF8B583E9BQ34598400-27B626CF-6529-40BE-9840-71D8D4FBC552Q34795063-867707AA-630F-4817-84ED-8ED058D69FD3Q35088118-FF1CC029-790F-4BC5-BF10-1AFB350BE1DBQ35753414-9B22B9E4-1690-4FFF-9DD8-324514FA295FQ35754634-C3C000A1-C1AE-4896-84C4-9061020B3AA0Q35763987-F50A4577-7745-4F5E-965C-0697861DF93AQ35765428-48234B93-87C2-4536-9CF8-1D55CE5B32BDQ35973936-FE755D4F-7029-4323-97F8-F55AF6E3D07EQ36288319-8B207227-AA62-47BB-BB36-8512C57A13FEQ36421638-4C3EE337-1453-478E-B553-45F9024513F4Q36651930-933D2A92-7FBA-48A0-9419-960305831D23Q36742206-BFB88E45-7B1C-4720-A7CE-BE6BFE2E3250Q36753692-18460B4C-359C-4CB8-8E23-D417358E3E85Q36886125-0700246B-A92F-4E3A-B743-49EFACC879C2Q37120518-DA23A194-CE3C-4DFC-A01A-A4DA2990A72AQ37284478-8D887526-B83D-446C-A82F-C6F18B1D1135Q37831160-6E2CC3CA-67DB-4920-AAD7-B0BDF750BB2AQ37832955-A38298A0-1C6E-46B0-8D0A-79EF03713871Q38501694-DA61EB8C-0904-4A9A-A893-2BB813E947CBQ39150091-48126D19-79CE-4228-83E0-690DF952EE64Q39708699-603E3FDA-019E-472A-A20B-B399FE9EB0F0Q40150706-DA7FD4FD-E9E9-4ACF-B82D-A1F40D6054E4Q40815452-826C5006-E468-4349-9EA4-052195181290Q42824252-A917FC18-E02E-4DED-A1D2-23F283C52AA7Q46171268-644A6B39-CB8A-4A2A-8994-CF007E2AFE74Q47315579-B5BDAA37-F7C0-4702-81B2-2962D0496F82Q48309021-848007E3-4EF2-415D-BF16-0C17C52FDE06Q53441049-54D467BC-E1DB-4A29-9370-75AE788D4BB0Q56566023-5BAEB8A7-D5D8-4E20-98B4-6B1A1A6FC454
P2860
Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Comparative genomic hybridizat ...... 1-q22 in soft tissue sarcomas.
@en
Comparative genomic hybridizat ...... 1-q22 in soft tissue sarcomas.
@nl
type
label
Comparative genomic hybridizat ...... 1-q22 in soft tissue sarcomas.
@en
Comparative genomic hybridizat ...... 1-q22 in soft tissue sarcomas.
@nl
prefLabel
Comparative genomic hybridizat ...... 1-q22 in soft tissue sarcomas.
@en
Comparative genomic hybridizat ...... 1-q22 in soft tissue sarcomas.
@nl
P2093
P356
P1476
Comparative genomic hybridizat ...... 1-q22 in soft tissue sarcomas.
@en
P2093
P356
10.1002/GCC.2870140103
P577
1995-09-01T00:00:00Z